|
|
Volumn 128, Issue 9, 1998, Pages 768-770
|
|
Heparin prophylaxis for medical patients?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ENOXAPARIN;
FIBRINOLYTIC AGENT;
HEPARIN;
HEPARIN DERIVATIVE;
LOW MOLECULAR WEIGHT HEPARIN;
NADROPARIN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DOUBLE BLIND PROCEDURE;
DRUG COST;
EDITORIAL;
EMBOLISM PREVENTION;
HEART INFARCTION;
HEPARINIZATION;
HIGH RISK PATIENT;
HUMAN;
LUNG EMBOLISM;
MAJOR CLINICAL STUDY;
META ANALYSIS;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STROKE;
SUBCUTANEOUS DRUG ADMINISTRATION;
VEIN THROMBOSIS;
|
|
EID: 0032080236
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-128-9-199805010-00011 Document Type: Editorial |
|
Times cited : (39)
|
|
References (23)
|
